2,3-Dimethoxy-12-(2-piperazin-1-yl-ethyl)-12H-8,10-dioxa-6,12-diaza-cyclopenta[b]chrysen-13-one

ID: ALA195792

PubChem CID: 11305763

Max Phase: Preclinical

Molecular Formula: C25H26N4O5

Molecular Weight: 462.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(=O)n(CCN3CCNCC3)c3c4cc5c(cc4ncc3c2cc1OC)OCO5

Standard InChI:  InChI=1S/C25H26N4O5/c1-31-20-9-15-16(10-21(20)32-2)25(30)29(8-7-28-5-3-26-4-6-28)24-17-11-22-23(34-14-33-22)12-19(17)27-13-18(15)24/h9-13,26H,3-8,14H2,1-2H3

Standard InChI Key:  OOEHOPSGXVHFSJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
   -0.0208   -0.2875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0208    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458   -0.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458    0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4583    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4583   -0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000    0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000    1.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4042    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1708    0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1708   -0.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0333    2.1958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458    1.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4042    2.1958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -0.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167    0.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167    1.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8833    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8833   -0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4042   -1.9500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458   -1.5250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9042    0.7000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9042    2.0375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3917    1.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8417   -2.7792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -1.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6000   -0.7125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6000    0.9625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4042   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -1.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8417   -1.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -3.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3208   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3208    0.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  2  1  0
  8  7  2  0
  9  7  1  0
 10  5  2  0
 11  6  2  0
 12  8  1  0
 13  4  1  0
 14  8  1  0
 15  1  1  0
 16  9  2  0
 17 16  1  0
 18 19  2  0
 19 11  1  0
 20 26  1  0
 21  3  2  0
 22 16  1  0
 23 17  1  0
 24 22  1  0
 25 31  1  0
 26 15  1  0
 27 19  1  0
 28 18  1  0
 29 20  1  0
 30 20  1  0
 31 30  1  0
 32 29  1  0
 33 27  1  0
 34 28  1  0
  5  4  1  0
 12 13  2  0
 25 32  1  0
 18 10  1  0
 17 14  2  0
 24 23  1  0
M  END

Associated Targets(Human)

RPMI 8402 (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 462.51Molecular Weight (Monoisotopic): 462.1903AlogP: 2.35#Rotatable Bonds: 5
Polar Surface Area: 87.08Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.22CX LogP: 1.55CX LogD: -0.26
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -0.51

References

1. Ruchelman AL, Houghton PJ, Zhou N, Liu A, Liu LF, LaVoie EJ..  (2005)  5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.,  48  (3): [PMID:15689163] [10.1021/jm049447z]
2. Zhou W, Dai Z, Chen Y, Yuan Z.  (2013)  Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues,  22  (1): [10.1007/s00044-012-0034-x]

Source